CardieX’s FDA clearance of its Conneqt Pulse blood pressure monitor expands its SphygmoCor technology for use in remote monitoring and self-monitoring at home. The firm is also developing a cuffless blood monitoring device for which it will seek FDA clearance.

In this final roundup of innovative health technologies showcased at CES 2023, Medtech Insight highlights three companies, Biobeat, Conneqt and Valencell, that are developing innovative technologies for cuffless blood pressure monitoring. Biobeat is the first company to receive US FDA clearance for a wearable to monitor blood pressure, but competition looms.